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Abstract
Common complications of thoracic radiotherapy include esophagitis and radiation pneumonitis.
However, it is important to be aware of uncommon post-radiotherapy complications such as
bronchiolitis obliterans organizing pneumonia (BOOP). We report on two patients with carcinoma
of the breast who developed an interstitial lung disease consistent with BOOP. BOOP responds to
treatment with corticosteroids and the prognosis is generally good despite of the need for long-
term administration of corticosteroids as relapses can occur during tapering of steroids. This
report provides guidelines for the evaluation and treatment of patients with pulmonary infiltrates
after radiotherapy.
Background
Radiation pneumonitis and fibrosis are well-recognized
complications of thoracic radiotherapy, but less common
complications include Bronchiolitis Obliterans Organiz-
ing Pneumonia (BOOP) and eosinophilic pneumonia
[1]. It is also not commonly appreciated that these com-
plications can manifest in patients receiving radiotherapy
for breast cancer. We report two such patients who devel-
oped a BOOP following post-operative radiotherapy to
the thoracic wall. The clinical features, diagnostic consid-
erations, and treatment of interstitial lung disease follow-
ing radiotherapy will serve to alert clinicians to this




A 59-year-old female who was a lifelong non-smoker
underwent a modified radical mastectomy in August 2002
for an adenocarcinoma of her left breast, staged
pT2N2M0. Adjuvant chemotherapy consisting of 4 cycles
of doxorubicin (60 mg/m2) with cyclofosfamide (600 mg/
m2) was administered from September to November
2002, followed by tamoxifen 20 mg daily. The patient was
then referred for adjuvant radiotherapy on the left tho-
racic wall and the axillary lymph nodes. After CT plan-
ning, she received radiation from 6th February to 20th
March 2003 to a total dose of 50 Gy in 25 fractions. The
thoracic wall was irradiated using tangential 6 Mv photon
fields, and regional lymph nodes using an anterior-poste-
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top-up field to the axilla. The V20, i.e. volume of total lung
receiving a dose of 20 Gy or more, was 32%.
In April 2003, the patient complained of shortness of
breath. Physical examination revealed a temperature of
38.0°C and pulmonary auscultation revealed inspiratory
crackles and bronchial breathing sounds. Peripheral O2
saturation was 97% measured by a pulse-oxymeter during
treatment with 2 litres of O2 a minute. Blood analysis
revealed a CRP of 189 mg/L(0–10 mg/L) and a one-hour
sedimentation rate of 105 mm/hour(0–30 mm/hour),
haemoglobin was 5.4 mmol/L(7.5–10.0 mmol/L), WBC
count was 6.0 × 109/L(4.4–10.0 × 109/L) with a slight
eosinophilia of 12%(0–5%), platelet count was 365 ×
109/L(150–400 × 109/L). Further serum chemistry, renal,
liver functions, and urinalysis were normal. A chest radio-
graph showed a patchy consolidation zone in the upper
lobe and the apex of the lower lobe of the left lung. Com-
puter tomography (CT) revealed multiple ground glass
opacities in the upper and lower lobe of the left lung, and
no abnormalities were seen in the right lung.
A clinical diagnosis of radiation pneumonitis was made
and treatment with prednisone 20 mg 3 times daily was
initiated, with an improvement in clinical symptoms seen
within 4 days. In the following months, the dose of pred-
nisone was gradually tapered to 15 mg once daily. The
chest radiograph in July 2003 showed a reduction of the
ground glass opacities. In August 2003, patient was hospi-
talised due to shortness of breath. A new CT showed an
increase of the patchy infiltrates in the left lung, but also
new patchy infiltrates in the middle lobe of the right lung
(figure 1). To rule out an infectious cause, a bronchoscopy
was performed which revealed no endobronchial abnor-
malities. No biopsies were performed but broncho-alveo-
lair lavage showed a normal cell count and negative
cultures. Consequently, a diagnosis of interstitial lung dis-
ease due to radiotherapy was made, most probably
BOOP, and the prednisone dosage was increased to 20 mg
four times daily. A clinical improvement was seen within
two weeks, after which the prednisone dosage was tapered
in the following 12 months. Radiological improvement
was observed in the right lung (figure 2). However, abnor-
malities consistent with radiation fibrosis remained
within the radiation field in the left lung.
Patient no.2
A 92-year-old patient presented with multiple intradermal
metastases from a breast cancer on the right thoracic wall
10 years after undergoing an amputation of the right
breast for a pT3N0M0 breast cancer. No adjuvant post-
surgical therapy was administered after the initial surgery.
Restaging revealed no regional or distant metastasis and
the chest wall lesions were resected. Pathological exami-
nation showed an irradical resection after which she was
referred for radiotherapy. She received thoracic and axil-
lary radiotherapy to a total dose of 60 Gy in once-daily
fractions of 2 Gy using non-CT based planning. Radio-
therapy to 50 Gy was performed using an anterior electron
field (10 MeV) matched to a lateral photon field (6 Mv)
dosed at 3 cm. The dose on the axilla was supplemented
using a posterior field. This was followed by a boost of 10
Gy to the site of irradical excision on the chest wall using
10 MeV electrons.
Three months after completing radiation therapy, the
patient was hospitalised for complaints of fever and short-
ness of breath. She was febrile (38.0°C) and auscultation
revealed bronchial breath sounds over the right lung
while no abnormalities were heard on the left side. The
one-hour sedimentation rate was 98 mm/hour(0–30
mm/hour), WBC count was 9.8 × 109/L(4.4–10.0 × 109/
L). Chest radiograph showed a density of the right upper
lobe and, to a lesser degree, the right lower lobe of the
lung. The left lung showed a normal pattern. Bronchos-
copy revealed no endobronchial abnormalities or evi-
dence for infection. Bronchial biopsies showed normal
tissue.
A diagnosis of radiation pneumonitis was made and high-
dose prednisone 40 mg once daily was started. The clinical
condition of patient improved significantly within two
weeks and patient was discharged. During follow up, the
improved clinical condition and radiological imaging
lead to a tapering of the prednisone, with discontinuation
after 6 months. The symptoms recurred two months later
and a chest radiograph showed an increase in the density
of the right lung and a density in the left upper lobe. As the
radiological abnormalities were migrating beyond the
radiation field, a diagnosis of BOOP following radiother-
apy was made. Treatment with prednisone 10 mg was
resumed and led to a resolution of her symptoms within
two weeks. The prednisone dose was gradually tapered
and totally discontinued again after 6 months.
Discussion
Despite the frequency of radiotherapy for breast cancer,
the development of interstitial lung disease complicating
this therapy is uncommon. A retrospective analysis in 451
patients found clinical symptoms and chest radiographs
compatible with radiation pneumonitis in 5.5% of breast
cancer patients [2]. Next to radiation pneumonitis, the
commonest interstitial lung diseases after radiotherapy
are BOOP and chronic eosinophilic pneumonia [1].
BOOP is a rare pulmonary disorder, which has wide range
of causes, such as infection, inhalation of toxic agents and
medication. BOOP is associated with the presence of
intraluminal plugs of connective tissue in bronchioles
extending to the alveoli, with a patchy distribution and aPage 2 of 5
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pathophysiology of BOOP after radiotherapy of the chest
is unknown.
The first radiographic change is usually a diffuse haze in
the irradiated lung, which progresses to patchy alveolar
infiltrates with air bronchograms [4]. A migratory pattern
of dense alveolar infiltrates in both radiated and non-irra-
diated lung zones can be seen [5-8]. Patients who have
received unilateral thoracic radiotherapy show activity on
a 18fluoro-2-deoxyglucose (FDG) positron emission tom-
ography (PET) in the ipsilateral and contralateral lung [9].
Common laboratory findings include polymorphonu-
clear leukocytosis and an elevated erythrocyte sedimenta-
tion rate. This sedimentation rate can be very high, up to
140 mm/h [7,8]. A bronchio-alveolar lavage (BAL) often
reveals a lymphocytosis, and both neutrophilia and eosi-
nophilia can also be found [7]. Open lung biopsy is the
preferred method for establishing the diagnosis [10],
however transbronchial biopsy has also been used [3].
From a radiological and clinical point of view, both
BOOP and radiation pneumonitis may have a similar
presentation. Radiation pneumonitis is also associated
with an interstitial pulmonary inflammation with also an
alveolar exudative component [11]. However, radiation
pneumonitis can lead to irreversible lung damage and
evolve to radiation fibrosis. BOOP tends to arise several
months after the completion of radiotherapy which is in
general longer than radiation pneumonitis [12]. While
CT shows patchy areas in the left lung and patchy areas in the middle lobe of the right lungFigure 1
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ated fields, migration of alveolar opacities is characteristic
of BOOP [13,14]. Both our patients were treated for a
radiation pneumonitis before the BOOP was diagnosed,
and while it is not possible to exclude BOOP as the initial
presentation, the initial symptoms were more compatible
with a radiation pneumonitis [15]. The mechanisms of
BOOP co-existing with radiation pneumonitis are
unknown [16], but both were present in both our
patients.
Unilateral irradiation for breast carcinoma has been
reported to induce an increase of lymphocytes with ele-
vated CD4/CD8 ratio in broncho-alveolar lavage fluid in
both the contralateral and ipsilateral lung soon after radi-
otherapy [17]. These infiltrates would spontaneously dis-
appear in most patients but might gradually consolidate
in a small number of patients and manifest as BOOP [12].
Some reports suggest that radiation pneumonitis is linked
to the combination of tamoxifen and radiotherapy [12],
but no such correlation was found for BOOP [18,19].
Apart from BOOP, chronic eosinophilic pneumonia has
also been described in patients after radiotherapy, and
almost exclusively in patients with a history of asthma or
allergy [1]. Clinical symptoms arising from this interstitial
lung disease are similar to those of BOOP, but blood and
BAL cell count do show a more pronounced eosinophilic
inflammation. The differential diagnosis of an interstitial
lung disease complicating radiation therapy includes radi-
CT shows an obvious improvement of the patchy infiltrates in the right lung after reintroduction of steroidsFigure 2
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ation pneumonitis, lymphangitis carcinomatosa and
infections such as tuberculosis, all of which can have
major clinical consequences for the patient [1,3,5-
8,12,14]. Due to a lack of awareness of the diagnosis,
invasive investigations like video assisted thoracoscopy
(VATS) have been performed in order to obtain a diagno-
sis. A bronchoscopy can exclude the other diagnoses [13].
We propose that a clinician should be aware of the possi-
bility of a BOOP in a post-radiotherapy setting, and after
exclusion of an infectious cause by bronchoscopy, is justi-
fied in starting treatment with corticosteroids. All reported
interstitial lung diseases in patients after radiotherapy irre-
spective of the precise diagnosis are described to respond
dramatically well to steroids [16]. In the largest patient
series described for BOOP, Epler recommended 1 mg/kg
for 1 to 3 months, then 40 mg/d for 3 months, then 10 to
20 mg/d or every other day for a total of 1 year. Treatment
shows spectacular improvement, clinically in one week
and radiological resolution usually follows in between 2
to 4 weeks [16]. Short-term therapy leads to recurrences
[7,8], which appear between one to six weeks of discon-
tinuation or tapering of the steroid treatment. The long-
term outcome of interstitial lung diseases after radiother-
apy appears excellent, when treatment with corticoster-
oids is initiated promptly [16]. In our second patient a
reduced dose of steroids was chosen because of the high
age of the patient.
Although not unique, we think that our case reports serve
to increase the awareness of clinicians to include intersti-
tial lung disease in the differential diagnosis of patients
presenting with lung infiltrates after radiotherapy. Addi-
tional investigations can be reserved for patients in whom
quick resolution of infiltrates is not observed.
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